77 %Among CXR-positive pneumonia cases, viruses accounted for 77% of pneumonia attribution.
Kenyapneumoniepublié 2021The Pediatric infectious disease journaleurope_pmcdocument de 10 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
6 677 evidences · page 172 / 268
77 %Among CXR-positive pneumonia cases, viruses accounted for 77% of pneumonia attribution.
Kenyapneumoniepublié 2021The Pediatric infectious disease journaleurope_pmcdocument de 10 observations
0,37 odds_ratioAnaemia burden was lower in HIV-positive non-injection substance users compared to HIV-negative non-injection substance users, with an odds ratio of 0.37.
Kenyaanémie · VIH/sidapublié 2022African health sciencesPubMeddocument de 7 observations
122 098 Kenyan ShillingsFinal diagnosis of necrotizing fasciitis cost 122,098 Kenyan Shillings more than non-necrotizing fasciitis diagnosis at Tenwek Hospital.
Kenyanecrotizing fasciitispublié 2020World journal of surgeryPubMeddocument de 8 observations
0,4 %The co-infection prevalence between Schistosoma haematobium and soil transmitted helminthes was 0.4% among women of reproductive age in Kwale County, Coastal Kenya.
Kenyaschistosomiase · soil transmitted helminthespublié 2022BMC public healthPubMeddocument de 14 observations
10,7 %About 10.7% of primary caregivers reported depressive symptoms.
Kenyadépressionpublié 2020BMC public healthPubMeddocument de 2 observations
95 %Epstein-Barr virus (EBV) affects greater than 95% of the global population.
Kenyavirus Epstein-Barrpublié 2026Cardiovascular journal of AfricaPubMeddocument de 3 observations
50,8 %Among HIV-infected women aged 18–48 years seeking reproductive healthcare in Eastern Kenya, 161 out of 317 participants (50.8%) were cases of cervical dysplasia.
Kenyacervical dysplasiapublié 2022African health sciencesPubMeddocument de 9 observations
3,2 %Sporozoite prevalence was 3.2% in Anopheles arabiensis.
Kenyapaludismeobservé 2020publié 2022Parasites & vectorsPubMeddocument de 6 observations
59,2 %Of the 135 HPV-positive women who were notified of their results, 77 (59.2%) sought treatment.
Kenyainfection à HPVobservé 2018publié 2021International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 7 observations
17 %The cervical cancer screening rate in Kenya currently stands at 16-18%.
Kenyacancer du col de l'utéruspublié 2024BMC women's healthPubMeddocument de 3 observations
23,34 %23.34% (95% CI 18.77–27.65) of cases of perinatal moderate-to-severe depressive symptoms were attributable to low social support.
Kenyaperinatal moderate-to-severe depressive symptomspublié 2022The lancet. PsychiatryPubMeddocument de 9 observations
14,62 %Treatment failure occurred in 74 out of 506 (14.62%) participants randomised to IV therapy within 1 year.
Kenyabone and joint infectionpublié 2019Health technology assessment (Winchester, England)europe_pmcdocument de 6 observationsDOI 10.3310/hta23380
1,29 timesIn Kenya, caregivers were 1.29 times more likely to receive early infant diagnosis (EID) results by 12 weeks of age with point-of-care (POC) versus laboratory-based EID.
KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations
91,2 %91.2% of women living with HIV in the study were virally suppressed.
KenyaVIH/sidapublié 2025PLoS medicinePubMeddocument de 14 observations
0,5 USDUnder study conditions, the cost per additional child correctly managed was 0.50 USD.
Kenyapaludismeobservé 2010publié 2012PloS oneeurope_pmcdocument de 5 observations
49 %A test positivity rate of ≥ 49% in all age groups corresponded to an age-standardized parasite prevalence of ≥ 30%.
Kenyapaludismepublié 2020PloS oneeurope_pmcdocument de 3 observationsDOI 10.1371/journal.pone.0240058
16 000 casesA gradual scale-up of the current 2-dose quadrivalent vaccine (4vHPV) program would avert an additional 16,000 cervical cancer cases compared with maintaining current program performance.
Kenyacancer du col de l'utérusPubMeddocument de 6 observations
98,73 %VECTRON™ T500 achieved 98.73% mortality against resistant Anopheles gambiae s.s. Bungoma strain.
Kenyapaludismepublié 2025Malaria journalPubMeddocument de 6 observations
75 %During maximum tolerated dose (MTD) of hydroxyurea, transfusion incidence was reduced by 75% compared to pre-treatment in African children with sickle cell anemia.
Kenyadrépanocytosepublié 2024American journal of hematologyPubMeddocument de 7 observations
2,4 %HIV prevalence among children tested via home-based testing was 2.4%.
KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 7 observations
1,27 risk_ratioPrevious cervical cancer screening was significantly associated with higher treatment uptake after testing high-risk HPV-positive (risk ratio 1.27, 95% CI 1.05–1.55).
Kenyahigh-risk HPVpublié 2022JMIR public health and surveillancePubMeddocument de 8 observations
1,32 aORSRI patients who had HIV were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.32.
KenyaCOVID-19 · VIH/sidaobservé July 2022 to October 2023publié 2026VaccinePubMeddocument de 8 observations
91 %Species identification of secondary malaria vectors using MALDI-TOF MS showed high concordance with Sanger sequencing with an overall accuracy of 91%.
Kenyapaludismepublié 2025Malaria journalPubMeddocument de 4 observations
92 %92.0% of primigravidae from the control arm were anaemic antenatally (Hb < 11 g/dl).
Kenyaanémiepublié 1998Tropical medicine & international health : TM & IHeurope_pmcdocument de 7 observations
11,8 %Against a Bungoma pyrethroid-resistant Anopheles gambiae s.s., mosquito mortality with PBO-LLINs dropped from 55.6% when new to 11.8% at 18 months.
Kenyapaludismepublié 2025PloS onePubMeddocument de 6 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.